Investigational Drug Information for Epetraborole
✉ Email this page to a colleague
What is the development status for investigational drug Epetraborole?
Epetraborole is an investigational drug.
There have been 4 clinical trials for Epetraborole.
The most recent clinical trial was a Phase 1 trial, which was initiated on May 1st 2022.
The most common disease conditions in clinical trials are Renal Insufficiency, Lung Diseases, and [disabled in preview]. The leading clinical trial sponsors are AN2 Therapeutics, Inc and [disabled in preview].
There are two US patents protecting this investigational drug and fifty-one international patents.
Summary for Epetraborole
| US Patents | 2 |
| International Patents | 51 |
| US Patent Applications | 17 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 7 |
| Clinical Trial Progress | Phase 1 (2022-05-01) |
| Vendors | 23 |
Recent Clinical Trials for Epetraborole
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects | AN2 Therapeutics, Inc | Phase 1 |
| Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease | AN2 Therapeutics, Inc | Phase 2/Phase 3 |
| A Phase 1 of Epetraborole Tablets | AN2 Therapeutics, Inc | Phase 1 |
Clinical Trial Summary for Epetraborole
Top disease conditions for Epetraborole
Top clinical trial sponsors for Epetraborole
US Patents for Epetraborole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Epetraborole | ⤷ Subscribe | Methods for treating bacterial infections | NEOCULI PTY LTD (Victoria, AU) | ⤷ Subscribe |
| Epetraborole | ⤷ Subscribe | Methods for treating bacterial infections | NEOCULI PTY LTD (Victoria, AU) | ⤷ Subscribe |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Epetraborole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Epetraborole | Argentina | AR067105 | 2027-06-20 | ⤷ Subscribe |
| Epetraborole | Australia | AU2008265630 | 2027-06-20 | ⤷ Subscribe |
| Epetraborole | Brazil | BRPI0813450 | 2027-06-20 | ⤷ Subscribe |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
